Russian President Vladimir Putin revealed on the same day that Russia’s first and world’s first new crown vaccine had been approved and registered by the Ministry of health on the morning of the same day, and his daughter had taken the lead in vaccination, the people’s Daily overseas network quoted the Russian satellite news agency as reporting on the 11th. Putin stressed that the vaccine has been tested as necessary. < p > < p > subsequently, the Russian health minister said that the first registered new coronavirus vaccine, named “satellite-v”, was jointly developed by the Russian National Research Center for epidemiology and microbiology of gamaliya and the Russian direct investment fund. The new coronavirus vaccine enables vaccinators to develop long-term immunity, which can last for two years. < / P > < p > at the same time, the research and development of another new crown vaccine led by the Russian National virology and Biotechnology Research Center (also known as the “vector” Research Center) is “accelerating”. Anna popova, director of the Federal Bureau of consumer protection and public welfare supervision of the Russian Federation, said today (17th) that the second phase (i.e. clinical trial) of the new crown candidate vaccine led by the “vector” Research Center was opened today. A total of 300 volunteers aged between 18 and 60 participated in this stage, including 60 staff of the center. Mass production of the vaccine is planned to begin in November this year. < / P > < p > “all the volunteers felt good about themselves, there was no adverse reaction at all, and there was no even slight swelling at the injection site. Everyone’s temperature is absolutely normal. ” Popova said. < / P > < p > and when asked which of the registered “satellite-v” vaccines and the vaccines developed under the leadership of the vector research center are more effective, popova stressed, “it is certain that each country – as well as Russia – should have several different new coronal vaccines. That’s what we’re doing today. ” The first batch of “satellite-v” vaccines have been produced on August 15, Russia reported on the 17th today. Russia’s mass vaccination may start in December this year or January next year. At present, more than 20 countries around the world have applied to Russia to buy 1 billion doses of vaccine. In addition, Russia has agreed to produce vaccines in five countries, with an estimated 500 million doses per year. Alexander kinzburg, director of Russia’s National Research Center for epidemiology and microbiology of gamaliya, said in an interview on the 15th that the third phase of satellite-v Research (after registration) may be launched within the next 7-10 days for a period of 5 months. < / P > < p > “on Monday, we will submit the first version of the post registration protocol. In view of the great public and media attention, I don’t think the Ministry of health will delay this process and will approve the agreement within a week. So I believe that within 7 to 10 days at most, everything will start. ” By the third stage, tens of thousands of people are expected to take part, says Ginsberg. < / P > < p > < p > < p > “satellite-v” vaccine came out so quickly that some European and American public health officials publicly questioned its safety and effectiveness and warned that the vaccine should not be put into mass production until the third phase of large-scale trials. < / P > < p > in addition to external doubts, there are also many queries in Russia itself. Although Russian officials claimed the safety of the vaccine, percent of Russian doctors surveyed online of 3040 Russian doctors said they were not ready for the satellite-v vaccine and only 24.5 percent were willing to do so, Reuters reported on the 14th. < / P > < p > at the same time, a poll conducted by Russian news website rambler showed that 48% of respondents did not trust the vaccine produced in their country. Their explanation is that, in their view, “vaccines are being produced too fast.”. 33% of Russians believe in the “satellite-v” vaccine. They believe that Russia is no worse than other countries in vaccine research and development. A further 19% of the respondents said they still had some concerns about the Russian vaccine (but their attitude was not so clear).